.png)
Men seek care later, and this is not a new observation. It actually shows up consistently across cardiovascular disease, type 2 diabetes, mental health, and cancer screening. By the time a symptom prompts a clinical visit, the underlying condition has often been developing for months or longer. The clinical record captures a point in time. The trajectory that led to that point is largely invisible.
Movember exists because of that gap. Every November, the campaign directs attention to men's health in four areas like prostate cancer, testicular cancer, mental health, and suicide prevention, where early detection and intervention change outcomes in ways that late-stage treatment cannot. The case for catching things earlier is well established. What has changed is the infrastructure available to actually do it.
Continuous monitoring through wearable devices offers a window into what happens between clinical touchpoints. For men who engage less with preventive care, that window is not supplementary, it may be the only window that exists.
The reluctance to seek care is real, but framing the men's health gap as purely a cultural or attitudinal problem misses something important. The healthcare system is designed around episodic contact: a GP visit, a screening appointment, an emergency presentation. For people who engage with that system infrequently, the gaps between contact points are where risk accumulates unobserved.
Men are, on average, less likely to have a regular GP, less likely to attend preventive screening, and more likely to present for the first time with a condition already in a later stage. Research consistently bears this out: in England, women aged 15 to 80 had significantly more GP consultations than men across all age groups, with the largest gap in the 20 to 44 age group. A US study found that men with health problems are more likely than women to have had no recent contact with a doctor, regardless of income or ethnicity. The consequences are measurable — deaths from melanoma are 50% higher in men than in women, despite men having a 50% lower incidence of the disease, a gap that reflects late presentation rather than biology. As the WHO European Region review on the social determinants of health concluded, men "are less likely to visit a doctor when they are ill and, when they see a doctor, are less likely to report on the symptoms of disease or illness."
The result is that health problems in men are often caught later than they need to be. Not because the signals were not there, but because there was no mechanism in place to see them.
Wearable devices generate continuous physiological and behavioral signals in the spaces between clinical touchpoints. We talked about the importance of wearables in between the lab tests in our Between Two Tests Whitepaper.
What makes this data relevant to early detection is not any single reading. It is the pattern across time, and what deviations from an individual's established baseline can indicate weeks before a symptom appears.
Several signals are particularly relevant in the men's health context:
None of these signals is diagnostic on its own. But deviations from an individual's personal baseline, not population averages, are meaningful in ways that a single clinical measurement cannot capture, precisely because they reflect change in that specific person over time.
Cardiovascular disease is the leading cause of death in men globally, and it disproportionately affects men at younger ages than women. The physiological trajectory toward a cardiac event, rising resting heart rate, declining HRV, increasing blood pressure, deteriorating sleep, develops over months or years before a clinical presentation.
Wearable data creates visibility into that trajectory. A man whose resting heart rate has trended upward by eight beats per minute over six weeks, whose HRV has been declining, and whose sleep quality has degraded is showing a pattern worth investigating. That pattern may appear long before he would consider booking a GP appointment.
For health insurers and digital health platforms, this is precisely the population where early engagement has the highest clinical and financial return. The intervention window is open. The question is whether the monitoring infrastructure exists to see it.
Type 2 diabetes develops gradually, and many men are diagnosed only when they present with symptoms that have already been developing for years. Activity levels, sleep quality, and resting heart rate all carry signal about metabolic health. Declining physical activity, disrupted sleep, and elevated resting heart rate are associated with insulin resistance and metabolic deterioration.
Wearable data alone cannot diagnose metabolic risk, but it can identify the behavioral and physiological patterns associated with it and prompt the clinical follow-up — a blood glucose test, a GP visit, that would otherwise not happen. For a population that underuses preventive screening, that prompting function is not trivial.
Movember's mental health and suicide prevention focus reflects a stark reality: men are significantly less likely to seek help for mental health conditions and account for the large majority of suicide deaths globally. The gap between experiencing a mental health problem and seeking treatment can span years.
Wearable data offers an indirect but meaningful window. Physiological stress markers, elevated resting heart rate, suppressed HRV, disrupted sleep, correlate with psychological stress, anxiety, and depression. These are not mental health diagnoses, but they are objective signals that something is changing, at a time when self-report is unreliable and professional help has not been sought.
An engagement layer built on these signals, a check-in prompt, a resource surfaced at the right moment, an outreach from a care team, does not replace mental health care. But it creates a touchpoint in the gap where no touchpoint currently exists.
Having access to continuous health data is not the same as acting on it. The signal only matters if it connects to something, a prompt, an alert, a conversation, an intervention. That connection is where most platforms currently fall short.
The intervention layer looks different depending on the context:
What all of these share is a dependency on the data infrastructure underneath them: normalized, continuous, individual-level data from whatever device the person happens to be using, delivered in a way that makes it actionable rather than archival.
Thryve's partnership with Movember is a direct expression of this belief. In 2024, Movember selected Thryve as its wearable data integration partner to scale the digital infrastructure behind its men's health programs. The challenge Movember faced before the partnership reflected the structural problem the whole sector encounters: rapid user growth during the November campaign, a narrow set of supported devices, inconsistent data, and compliance demands that an in-house system could not meet at scale.
Thryve's wearable API provided the infrastructure layer Movember needed:
"Thryve's integration not only builds our capabilities but also strengthens our mission to improve men's health worldwide. Their expertise and integration has expanded our ability to harness health data in a more efficient and reliable way. Now, we're able to leverage a wider array of wearable data that enables more personalized and impactful health insights for our community." — Chris Tan, Senior Product Manager at Movember
The result is a platform where Movember can reach a much larger and more diverse community of users with real-time health insights, without the operational overhead of managing device integrations independently.
The men's health gap is not going to close through awareness alone. It closes when the data infrastructure exists to see what is happening between clinical touchpoints, and when that data connects to interventions that reach men at the moment a signal appears, not months later at a clinical visit that may never happen.
If you are building a men's health program, a digital health platform, or an insurance product that needs to reach members earlier and more effectively, book a demo with Thryve.
Friedrich Lämmel is CEO of Thryve, the plug & play API to access and understand 24/7 health data from wearables and medical trackers. Prior to Thryve, he built eCommerce platforms with billions of turnover and worked and lived in several countries in Europe and beyond.
.png)
.png)